BioAegis Therapeutics Announces Publication: "Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Severe Influenza" - Associated Press Get link Facebook X Pinterest Email Other Apps December 17, 2019 BioAegis Therapeutics Announces Publication: "Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Severe Influenza" Associated Press Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment